FI980853A7 - Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta - Google Patents

Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta Download PDF

Info

Publication number
FI980853A7
FI980853A7 FI980853A FI980853A FI980853A7 FI 980853 A7 FI980853 A7 FI 980853A7 FI 980853 A FI980853 A FI 980853A FI 980853 A FI980853 A FI 980853A FI 980853 A7 FI980853 A7 FI 980853A7
Authority
FI
Finland
Prior art keywords
dna
making protein
new
new dna
protein
Prior art date
Application number
FI980853A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI980853A0 (fi
FI980853L (fi
Inventor
Tomonori Morinaga
Hisataka Yasuda
Nobuaki Nakagawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI980853A0 publication Critical patent/FI980853A0/fi
Publication of FI980853L publication Critical patent/FI980853L/fi
Publication of FI980853A7 publication Critical patent/FI980853A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI980853A 1996-08-19 1997-08-19 Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta FI980853A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規dna及びそれを用いた蛋白質の製造方法
PCT/JP1997/002859 WO1998007840A1 (fr) 1996-08-19 1997-08-19 Nouveaux adn et procede de production de proteines a l'aide de ces derniers

Publications (3)

Publication Number Publication Date
FI980853A0 FI980853A0 (fi) 1998-04-17
FI980853L FI980853L (fi) 1998-06-15
FI980853A7 true FI980853A7 (fi) 1998-06-15

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980853A FI980853A7 (fi) 1996-08-19 1997-08-19 Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta

Country Status (12)

Country Link
EP (1) EP0874045A1 (cg-RX-API-DMAC7.html)
JP (1) JPH1057071A (cg-RX-API-DMAC7.html)
KR (1) KR20000064276A (cg-RX-API-DMAC7.html)
CN (1) CN1198776A (cg-RX-API-DMAC7.html)
AU (1) AU718458B2 (cg-RX-API-DMAC7.html)
CA (1) CA2235148A1 (cg-RX-API-DMAC7.html)
FI (1) FI980853A7 (cg-RX-API-DMAC7.html)
HU (1) HUP0001837A3 (cg-RX-API-DMAC7.html)
NO (1) NO981748L (cg-RX-API-DMAC7.html)
NZ (1) NZ330400A (cg-RX-API-DMAC7.html)
WO (1) WO1998007840A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA977402B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6017729A (en) 1996-12-23 2000-01-25 Immunex Corporation Receptor activator of NF-κB
CA2781623A1 (en) 1997-04-15 1998-10-22 Daiichi Sankyo Company, Limited Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
ID23855A (id) 1997-04-16 2000-05-25 Amgen Inc Protein pengikat osteoprotegerin dan reseptor
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
NZ335759A (en) 1997-09-24 2002-02-01 Sankyo Co Method of diagnosing metabolic bone diseases by measuring osteoclastgenesis inhibitory factor (OCIF)
ES2317694T3 (es) 1998-05-14 2009-04-16 Immunex Corporation Metodo para inhibir la actividad osteoclastica.
EP1127578A4 (en) 1998-10-28 2004-12-15 Sankyo Co MEDICINE FOR BONE METABOLIC DEVIATIONS
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
WO2001023562A2 (en) * 1999-09-27 2001-04-05 Eli Lilly And Company Osteoprotegerin regulatory region
EP1377610A2 (en) 2001-04-03 2004-01-07 Société des Produits Nestlé S.A. Osteoprotegerin in milk
KR100942393B1 (ko) 2001-05-25 2010-02-17 휴먼 게놈 사이언시즈, 인코포레이티드 Trail 수용체에 면역특이적으로 결합하는 항체
CA2481074A1 (en) 2002-04-05 2003-10-23 Amgen Inc. Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
NZ330400A (en) 1999-05-28
NO981748D0 (no) 1998-04-17
AU718458B2 (en) 2000-04-13
EP0874045A1 (en) 1998-10-28
FI980853A0 (fi) 1998-04-17
FI980853L (fi) 1998-06-15
JPH1057071A (ja) 1998-03-03
MX9803086A (es) 1998-11-29
WO1998007840A1 (fr) 1998-02-26
NO981748L (no) 1998-06-18
KR20000064276A (ko) 2000-11-06
ZA977402B (en) 1999-02-18
HUP0001837A2 (hu) 2000-09-28
AU3866197A (en) 1998-05-11
EP0874045A4 (cg-RX-API-DMAC7.html) 1998-11-18
CN1198776A (zh) 1998-11-11
CA2235148A1 (en) 1998-02-26
HUP0001837A3 (en) 2002-09-30

Similar Documents

Publication Publication Date Title
FI974016L (fi) Proteiinisideaine ja menetelmä proteiinisideaineen muodostamiseksi
FI973402L (fi) Uusia proteiineja ja menetelmiä proteiinien tuottamiseksi
FI972429A0 (fi) Menetelmä ja laite DNA:n sekvensoimiseksi ja DNA:n identifioimiseksi
DE69530277D1 (de) Verfahren zur auswahl von übertragungsvorzügen
IS8368A (is) Ný aðferð
FI970648A7 (fi) Menetelmä nukleiinihappojen jakelemiseksi
IL120337A0 (en) Method for joining DNA fragments
FI980853L (fi) Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta
GB2293883B (en) Method for measuring protein concentration using a protein biosensor
AU1683795A (en) Method for determining protein tertiary structure
DE69514851D1 (de) Interatomares Messverfahren
IS5106A (is) Ný aðferð
FI940316L (fi) Menetelmä heraproteiinien fraktioimiseksi
EE03643B1 (et) Meetod ja süsteem sümbolijada vastuvõtmiseks
FI971100L (fi) Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi
FI964657L (fi) Geenitestausmenetelmä
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
FI980945L (fi) Menetelmä proteiinien eristämiseksi ja muuntelemiseksi
FI972055L (fi) Syljen analysointimenetelmä
FI982487L (fi) Menetelmä ja järjestelmä V5-liitännän hallitsemiseksi
DE69724736D1 (de) Prozessablaufsteuerung
FI954684L (fi) Imidobisfosforihapot, menetelmä niiden valmistamiseksi ja niiden käyttö
FI100322B (fi) Menetelmä kaavinpalkkijärjestelyn käyttöön ja kaavinpalkkijärjestely
FI980758A0 (fi) Menetelmä vanerin valmistamiseksi
GB9706078D0 (en) Screening method and proteins and dna identified thereby